2025-05-14 - Analysis Report
Okay, here's the analysis of Merck & Co Inc (MRK), presented in English with a focus on key data points and their implications:

## MRK (Merck & Co Inc) Stock Analysis

**Merck & Co Inc is a global pharmaceutical company that develops and provides a broad range of innovative medicines, vaccines, and animal health products.**

### 1. Performance Relative to S&P 500 (VOO)

*   **MRK Cumulative Return:** 2.42%
*   **VOO Cumulative Return:** 81.82%
*   **Relative Deviation:**
    *   **Current:** -79.4%
    *   **Max:** 23.9%
    *   **Min:** -80.6%
    *   **Relative Deviation Percentile:** 1.1%

**Analysis:** MRK has significantly underperformed the S&P 500 (VOO) over the analyzed period.  The -79.4% deviation indicates a substantial gap in returns.  The relative deviation percentile of 1.1% suggests MRK's underperformance is near its worst levels compared to its historical range relative to the S&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD    | Alpha   | Beta   | Cap(B) |
| :----------- | :----- | :----- | :------ | :----- | :----- |
| 2015-2017  | 5.0%   | 58.4%  | -24.0%  | 0.0    | 108.3  |
| 2016-2018  | 42.0%  | 66.6%  | 24.0%   | 0.1    | 151.6  |
| 2017-2019  | 40.0%  | 66.6%  | 11.0%   | 0.2    | 185.4  |
| 2018-2020  | 19.0%  | 66.6%  | -6.0%   | 0.4    | 172.0  |
| 2019-2021  | -1.0%  | 65.6%  | -55.0%  | 0.5    | 175.1  |
| 2020-2022  | 13.0%  | 69.3%  | 7.0%    | 0.5    | 261.6  |
| 2021-2023  | 35.0%  | 69.3%  | 19.0%   | 0.3    | 264.2  |
| 2022-2024  | -6.0%  | 69.3%  | -23.0%  | 0.3    | 247.7  |
| 2023-2025  | -51.0% | 70.3%  | -80.0%  | 0.7    | 192.4  |

**Analysis:**

*   **CAGR:** Fluctuates significantly, with recent periods showing substantial negative growth.
*   **MDD:** High Maximum Drawdown values indicate significant potential losses.
*   **Alpha:**  Consistently negative Alpha in recent periods suggests underperformance relative to the market risk-free rate.
*   **Beta:**  Beta values are relatively low (below 1), indicating MRK is less volatile than the overall market. The recent increase to 0.7 suggests increased sensitivity.
*   **Cap:** Market capitalization has fluctuated, declining recently.

### 2. Recent Price Action

*   **Current Price:** $76.63
*   **Previous Close:** $80.43
*   **Change:** -4.72%
*   **5-Day Moving Average:** 77.96
*   **20-Day Moving Average:** 80.11
*   **60-Day Moving Average:** 85.90

**Analysis:** The stock price has recently declined, as evidenced by the negative change and the fact that the current price is below all three moving averages. The 5-day moving average is below the 20-day moving average, and both are below the 60-day moving average, confirming a short-term downtrend. The large negative change relative to the previous close (-4.72%) suggests a significant negative event or market sentiment shift.

### 3. Technical Indicators

*   **Market Risk Indicator (MRI):** 0.348 (Low Risk)
*   **RSI:** 45.62
*   **PPO:** -0.22
*   **20-Day Relative Deviation Change:** -11.4 (Negative)
*   **Expected Return:** -982.2%

**Analysis:**

*   **MRI:** The MRI suggests a low-risk environment currently.
*   **RSI:** The RSI is below 50, indicating bearish momentum, but not yet oversold.
*   **PPO:** A negative PPO confirms the downtrend and suggests the short-term moving average is below the long-term moving average.
*   **20-Day Relative Deviation Change:** The negative change further emphasizes the recent underperformance relative to the benchmark.
*   **Expected Return:** The extremely negative expected return suggests significant potential underperformance compared to the S&P 500 over a long-term investment horizon. **This is a concerning signal.**

### 4. Recent News & Significant Events

*   **2025-05-11:** Major business developments, regulatory changes, or market events.
*   **2025-05-14:** Analysts discussing performance in the context of industry trends and global economic factors.
*   **2025-05-13:** Notable stock volatility.
*   **2025-05-12:** Market experts highlighting risks and opportunities.

**Analysis:** The recent news suggests a period of significant change and volatility for MRK, with both potential risks and opportunities identified. It's crucial to investigate the specific details of these events to understand their impact fully. The volatility indicated in the news aligns with the recent price drop.

### 5. Recent Earnings Analysis

| 날짜       | EPS  | 매출     |
| :--------- | :--- | :------- |
| 2025-05-02 | 2.01 | 15.53 B$ |
| 2024-11-06 | 1.25 | 16.66 B$ |
| 2024-08-05 | 2.15 | 16.11 B$ |
| 2024-05-03 | 1.88 | 15.78 B$ |
| 2025-05-02 | 1.88 | 15.78 B$ |

**Analysis:** The earnings data shows fluctuations in both EPS and Revenue. It's important to analyze these figures in comparison to previous years and analyst expectations to understand whether the company is meeting its targets. The inconsistency in EPS could be a concern.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue   | Profit Margin |
| :--------- | :-------- | :------------ |
| 2025-03-31 | $15.53B  | 77.98%        |
| 2024-12-31 | $15.62B  | 75.50%        |
| 2024-09-30 | $16.66B  | 75.51%        |
| 2024-06-30 | $16.11B  | 76.76%        |
| 2024-03-31 | $15.78B  | 77.56%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE      |
| :--------- | :-------- | :------- |
| 2025-03-31 | $48.34B  | 10.51%   |
| 2024-12-31 | $46.31B  | 8.08%    |
| 2024-09-30 | $44.50B  | 7.09%    |
| 2024-06-30 | $43.58B  | 12.52%   |
| 2024-03-31 | $40.36B  | 11.80%   |

**Analysis:**

*   **Revenue:** Revenue has been relatively stable over the past year, with a slight decrease in the most recent quarter.
*   **Profit Margin:** Profit margins are high, indicating strong profitability.
*   **Equity:**  Equity has been increasing, indicating growth in the company's net assets.
*   **ROE:** ROE (Return on Equity) has fluctuated, indicating varying levels of profitability relative to equity. The most recent ROE is slightly lower than previous quarters.

### 7. Overall Assessment

Based on the provided data, MRK is currently facing several challenges:

*   **Significant Underperformance:**  It has significantly underperformed the S&P 500, with a concerningly low relative deviation percentile.
*   **Recent Downtrend:** The stock price is in a short-term downtrend and experienced a notable drop recently.
*   **Negative Expected Return:** The highly negative expected return signals a potential for continued underperformance compared to the S&P 500.
*   **Recent News & Volatility:** Recent news suggests a period of change and volatility.
*   **Mixed Financials:** While profit margins are strong, revenue growth is sluggish, and ROE has fluctuated.

**Recommendation:**  Given the underperformance, downtrend, and negative expected return, a cautious approach is warranted.  Further research is needed to understand the reasons behind the recent negative events and the company's plans to address these challenges.  Investors should closely monitor upcoming earnings reports and company announcements before making any investment decisions.  The news regarding "major business developments, regulatory changes, or market events" should be thoroughly investigated.
